• Topics

  • Formats

Organiser: Pharmaphorum

“AI has arrived,” British Prime Minister Keir Starmer declared in a recent speech. “Our defining opportunity is here - and together, we will harness it”, he added, praising the potential of artificial intelligence to drive growth, foster innovation, and “transform public services”.

Of particular focus in the Prime Minister’s comments has been the role of AI in building a future-ready National Health Service (NHS). New announcements appear to back up his claims, including the publication of new NICE guidance approving the use of four AI technologies as a tool for improving fracture detection in X-rays in urgent care settings.

Across the Atlantic, the FDA has recognised AI’s growing presence in drug development across a range of therapeutic areas, acknowledging it particularly for its role in improving efficiency, enhancing diagnostics, and enabling more personalised patient care.

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?